Mutagenicity Study of a New Antineoplastic Agent S-1, and Its Components, Cdhp; And Oxo

Ohuchida, Akinobu; Kouchi, Yasuhide; Sato, Sachiko; Maeda, Yasuhiro

doi:10.2131/jts.21.supplementiii_675

Cited by 4 publications

(1 citation statement)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The results presented here are in agreement with the reported activities for some pyrimidine derivatives. Thus, it has been demonstrated that some fluorinated pyrimidine derivatives produced a clear clastogenic effect, inducing chromosomal aberrations in Chinese hamster cells (Yajima et al 1981;Shibahara et al 1993;Ohuchida et al 1996) and micronuclei in mouse bone marrow (Shibahara et al 1993), and gave a negative response in a reverse mutation test in strains of S. typhimurium (Yajima et al 1981;Shibahara et al 1993;Ohuchida et al 1996).…”

Section: Discussionmentioning

confidence: 99%

Genotoxicity study of a new tetraalkylammonium derivative of 6-methyluracil (agent No. 547)

Karamova

Ivanchenko

Ilinskaya

et al. 2002

Archives of Toxicology

View full text Add to dashboard Cite

Agent No. 547 (1,3-bis[omega-(diethyl-ortho-nitrobenzylammonio)-pentyl]-6-methyluracil dibromide), a newly synthesized inhibitor of mammalian-specific acetyltcholinesterase (EC 3.1.1.7) was investigated for genotoxicity using the DNA-repair test, Ames test and in vivo micronucleus test with mouse peripheral blood erythrocytes. Agent No. 547 did not cause significant changes in growth of repair-deficient Escherichia coli tester strains. The compound was non-mutagenic in Salmonella typhimurium strains TA98 and TA100 with and without rat microsomal activation mixture. However, we observed a marked increase in number of His(+) revertants for both tester strains in preincubation assays. The results obtained in the micronucleus test indicate that agent No. 547 possesses significant clastogenic activity. At the high dose tested (0.5 mg/kg), the compound induced a seven-fold increase in the number of micronuclei over the spontaneous background 48 h after treatment. The results suggest that further work should be promoted to identify the metabolic pathways involved in genotoxicity of agent No. 547 in mammalian cells and to evaluate the real risk of its exposure.

show abstract